Results 261 to 270 of about 296,701 (305)

In-Stent Restenosis

2018
Restenosis is an arterial wall healing response to mechanical injury at the site of a previously treated coronary segment. In-stent restenosis (ISR) is an angiographic diagnosis, defined as recurrent diameter stenosis >50% within a stent or at its edges (5 mm segments proximal and distal to the stent).
Roisin Colleran, Robert A. Byrne
openaire   +2 more sources

In-Stent Restenosis

Interventional Cardiology Clinics, 2022
In-stent restenosis (ISR) remains a potential complication after percutaneous coronary intervention, even in the era of drug-eluting stents, and its treatment remains suboptimal. Neoatherosclerosis is an important component of the pathology of ISR and is accelerated in drug-eluting stents compared with bare-metal stents.
Kenji, Kawai, Renu, Virmani, Aloke V, Finn   +2 more
openaire   +2 more sources

Preventing treatment failures in coronary artery disease: what can we learn from the biology of in-stent restenosis, vein graft failure and internal thoracic arteries?

Cardiovascular Research, 2020
Coronary artery disease (CAD) remains one of the most important causes of morbidity and mortality worldwide, and the availability of percutaneous or surgical revascularization procedures significantly improves survival.
C. Spadaccio, C. Antoniades, A. Nenna, Calvin Chung, Ricardo Will, M. Chello, M. Gaudino   +6 more
semanticscholar   +1 more source

Stenting for in-stent restenosis

Catheterization and Cardiovascular Interventions, 2000
Intravascular ultrasound studies have shown that additional stent implantation is the only percutaneous technique that allows for recovery of all the lumen area of the original implantation procedure. Despite this theoretical advantage, information on systematic additional stent implantation is still forthcoming, especially concerning the impact of new
D, Antoniucci, R, Valenti, G, Moschi, M, Trapani, G M, Santoro, L, Bolognese, E, Taddeucci, E, Dovellini   +7 more
openaire   +2 more sources

Outcomes of intravascular brachytherapy for recurrent drug‐eluting in‐stent restenosis

Catheterization and cardiovascular interventions, 2020
To examine the outcomes of vascular brachytherapy (VBT) for recurrent drug‐eluting stents (DES) in‐stent restenosis (ISR).
M. Megaly, Matthew Glogoza, Iosif Xenogiannis, E. Vemmou, Ilias Nikolakopoulos, Laura Willson, D. Monyak, Patsa Sullivan, L. Stanberry, P. Sorajja, Ivan J. Chavez, M. Mooney, J. Traverse, Yale Wang, S. Garcia, A. Poulose, M. Burke, E. Brilakis   +17 more
semanticscholar   +1 more source

Restenosis after aortic stenting

Cardiology in the Young, 2004
Aortic coarctation is a recognized arteriopathy in patients with Williams’ syndrome. We present an adolescent with Williams’ syndrome who developed rapid restenosis after primary stenting of coarctation of the aorta. We believe such restenosis within the stent is due to a proliferative response of the abnormal aortic wall.
Joydeep, Mookerjee, Derek, Roebuck, Graham, Derrick   +2 more
openaire   +2 more sources

Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial.

Journal of the American Medical Association (JAMA)
Importance Drug-coated balloons offer a potentially beneficial treatment strategy for the management of coronary in-stent restenosis. However, none have been previously evaluated or approved for use in coronary circulation in the United States ...
Robert W. Yeh, R. Shlofmitz, Jeffrey Moses, William B. Bachinsky, S. Dohad, Steven G. Rudick, R. Stoler, Brian K Jefferson, William Nicholson, John D. Altman, Cinthia T. Bateman, Amar Krishnaswamy, J. Grantham, Frank J. Zidar, S. Marso, J. Tremmel, Cindy Grines, Mustafa I. Ahmed, A. Latib, Behnam N. Tehrani, J. Abbott, Wayne B. Batchelor, Paul Underwood, Dominic Allocco, Ajay J. Kirtane, R. Shlofmitz, Jeffrey Moses, William B. Bachinsky, S. Dohad, Steven G. Rudick, R. Stoler, Brian K Jefferson, William Nicholson, John D. Altman, Robert W. Yeh, Cinthia T. Bateman, Amar Krishnaswamy, J. Grantham, Frank J. Zidar, Rajendran Sabapathy, J. Tremmel, Cindy Grines, Mustafa I. Ahmed, A. Latib, Behnam N. Tehrani, K. Alaswad, Carey Kimmelstiel, William Dixon, Arthur Reitman, Lawrence Ang, Justin Levisay, J. Abbott, Kathleen Kearney, F. Jaffer, Saroj Neupane, Kevin Croce, K. Shunk, Angela Taylor, Matthew Saybolt, Claro F Diaz, Alpesh Shah, K. Lotun, Johannes Brechtken, Himanshu Agarwal, Rajan Patel   +64 more
semanticscholar   +1 more source

Intracoronary Stent Restenosis

2021
Despite contemporary drug-eluting stent (DES) technology, intracoronary stent restenosis (ISR) occurs in up to 10% of patients, increasing with intervention of complex lesions. The presentation of ISR is still challenging for optimal treatment [1].
Keisuke Yasumura, Annapoorna Kini, Samin K. Sharma   +2 more
openaire   +1 more source

Treatment of coronary in-stent restenosis: a systematic review

Journal of Geriatric Cardiology, 2018
Coronary stent implantation has significantly improved percutaneous coronary intervention and enabled the management of early complications of plain balloon angioplasty. However, a new complication has accompanied these improvements: in-stent restenosis (
L. Pleva, Pavel Kukla, O. Hlinomaz
semanticscholar   +1 more source

The effectiveness of excimer laser angioplasty to treat coronary in-stent restenosis with peri-stent calcium as assessed by optical coherence tomography.

EuroIntervention, 2017
AIMS We aimed to evaluate the effectiveness of excimer laser coronary angioplasty (ELCA) to treat in-stent restenosis (ISR) due to peri-stent calcium-related stent underexpansion as assessed by optical coherence tomography (OCT). METHODS AND RESULTS We
Tetsumin Lee, R. Shlofmitz, Lei Song, Theofanis Tsiamtsiouris, T. Pappas, Antonio Madrid, A. Jeremias, E. Haag, Z. Ali, J. Moses, M. Matsumura, G. Mintz, A. Maehara   +12 more
semanticscholar   +1 more source